These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


237 related items for PubMed ID: 20666497

  • 1. Predicting polypharmacology by binding site similarity: from kinases to the protein universe.
    Milletti F, Vulpetti A.
    J Chem Inf Model; 2010 Aug 23; 50(8):1418-31. PubMed ID: 20666497
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
    Verkhivker GM.
    Proteins; 2007 Mar 01; 66(4):912-29. PubMed ID: 17173284
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology.
    Aronov AM, McClain B, Moody CS, Murcko MA.
    J Med Chem; 2008 Mar 13; 51(5):1214-22. PubMed ID: 18288794
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors.
    Liao JJ.
    J Med Chem; 2007 Feb 08; 50(3):409-24. PubMed ID: 17266192
    [No Abstract] [Full Text] [Related]

  • 16. Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides.
    Schirmer A, Kennedy J, Murli S, Reid R, Santi DV.
    Proc Natl Acad Sci U S A; 2006 Mar 14; 103(11):4234-9. PubMed ID: 16537514
    [Abstract] [Full Text] [Related]

  • 17. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
    Traxler P, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N.
    J Pharm Belg; 1997 Mar 14; 52(2):88-96. PubMed ID: 9193132
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors.
    Laufer SA, Domeyer DM, Scior TR, Albrecht W, Hauser DR.
    J Med Chem; 2005 Feb 10; 48(3):710-22. PubMed ID: 15689155
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.